183 related articles for article (PubMed ID: 21562723)
1. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease.
Choi J; Lee HW; Suk K
J Neurol; 2011 Dec; 258(12):2181-5. PubMed ID: 21562723
[TBL] [Abstract][Full Text] [Related]
2. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
Craig-Schapiro R; Perrin RJ; Roe CM; Xiong C; Carter D; Cairns NJ; Mintun MA; Peskind ER; Li G; Galasko DR; Clark CM; Quinn JF; D'Angelo G; Malone JP; Townsend RR; Morris JC; Fagan AM; Holtzman DM
Biol Psychiatry; 2010 Nov; 68(10):903-12. PubMed ID: 21035623
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia.
Kulczyńska-Przybik A; Słowik A; Mroczko P; Borawski B; Groblewska M; Borawska R; Mroczko B
Curr Alzheimer Res; 2020; 17(8):709-721. PubMed ID: 33167838
[TBL] [Abstract][Full Text] [Related]
5. Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
Letra L; Matafome P; Rodrigues T; Duro D; Lemos R; Baldeiras I; Patrício M; Castelo-Branco M; Caetano G; Seiça R; Santana I
J Alzheimers Dis; 2019; 67(2):725-735. PubMed ID: 30689587
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma levels of lipocalin 2 in mild cognitive impairment.
Choi J; Lee HW; Suk K
J Neurol Sci; 2011 Jun; 305(1-2):28-33. PubMed ID: 21463871
[TBL] [Abstract][Full Text] [Related]
7. Association of the Polymorphisms and Plasma Level of CHI3L1 with Alzheimer's Disease in the Chinese Han Population: A Case-Control Study.
Dai QH; Gong DK
Neuropsychobiology; 2019; 77(1):29-37. PubMed ID: 30223258
[TBL] [Abstract][Full Text] [Related]
8. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
[TBL] [Abstract][Full Text] [Related]
9. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease.
Moreno-Rodriguez M; Perez SE; Nadeem M; Malek-Ahmadi M; Mufson EJ
J Neuroinflammation; 2020 Feb; 17(1):58. PubMed ID: 32066474
[TBL] [Abstract][Full Text] [Related]
10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
11. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
[TBL] [Abstract][Full Text] [Related]
12. A Novel Plasma Based Biomarker of Alzheimer's Disease.
Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
[TBL] [Abstract][Full Text] [Related]
13. γH2AX is increased in peripheral blood lymphocytes of Alzheimer's disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging.
Siddiqui MS; Francois M; Hecker J; Faunt J; Fenech MF; Leifert WR
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():6-18. PubMed ID: 29704994
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma levels of chitinase 3-like 1 (CHI3L1) protein in patients with idiopathic normal-pressure hydrocephalus.
Ko PW; Lee HW; Lee M; Youn YC; Kim S; Kim JH; Kang K; Suk K
J Neurol Sci; 2021 Apr; 423():117353. PubMed ID: 33652290
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.
Oh J; Lee HJ; Song JH; Park SI; Kim H
Exp Gerontol; 2014 Dec; 60():87-91. PubMed ID: 25304332
[TBL] [Abstract][Full Text] [Related]
17. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
[TBL] [Abstract][Full Text] [Related]
19. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
[TBL] [Abstract][Full Text] [Related]
20. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
